Back to Search Start Over

Partial recovery of visual function in a blind patient after optogenetic therapy

Authors :
Laure Blouin
Jean-Baptiste de Saint Aubert
Deniz Dalkara
Joseph N. Martel
Alexandre Delaux
Simona Degli Esposti
Serge Picaud
Emmanuel Gutman
Francesco Galluppi
Chloé Pagot
Caroline de Montleau
Magali Taiel
Botond Roska
José-Alain Sahel
Elise Boulanger-Scemama
Angelo Arleo
Jens Duebel
Isabelle Audo
Institut de la Vision
Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)
Streetlab [Paris]
Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)
GenSight Biologics
Department of Ophthalmology, The University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
National Institute for Health Research Moorfields Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London
INSERM-Centre d'Investigation Clinique 1423, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, F-75012 Paris, France
University of Basel (Unibas)
ARLEO, Angelo
Centre National de la Recherche Scientifique (CNRS)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Centre National de la Recherche Scientifique (CNRS)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Department of Ophthalmology, University of Basel, Basel, Switzerland
Source :
Nature Medicine, Nature Medicine, 2021, ⟨10.1038/s41591-021-01351-4⟩, Nature Medicine, Nature Publishing Group, 2021, ⟨10.1038/s41591-021-01351-4⟩, Fac Rev
Publication Year :
2021
Publisher :
Springer Science and Business Media LLC, 2021.

Abstract

Optogenetics may enable mutation-independent, circuit-specific restoration of neuronal function in neurological diseases. Retinitis pigmentosa is a neurodegenerative eye disease where loss of photoreceptors can lead to complete blindness. In a blind patient, we combined intraocular injection of an adeno-associated viral vector encoding ChrimsonR with light stimulation via engineered goggles. The goggles detect local changes in light intensity and project corresponding light pulses onto the retina in real time to activate optogenetically transduced retinal ganglion cells. The patient perceived, located, counted and touched different objects using the vector-treated eye alone while wearing the goggles. During visual perception, multichannel electroencephalographic recordings revealed object-related activity above the visual cortex. The patient could not visually detect any objects before injection with or without the goggles or after injection without the goggles. This is the first reported case of partial functional recovery in a neurodegenerative disease after optogenetic therapy.

Details

ISSN :
1546170X, 10788956, and 17447933
Volume :
27
Database :
OpenAIRE
Journal :
Nature Medicine
Accession number :
edsair.doi.dedup.....257de8fe53fe42c57d84ef680abcb7d7
Full Text :
https://doi.org/10.1038/s41591-021-01351-4